Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • dollarsdollars298 dollarsdollars298 Nov 19, 2012 3:08 PM Flag

    Article Says: Moving Higher With or Without Early approval. LINK

    Thanks to who ever posted this :
    Article Says: Moving Higher With or Without Early approval. LINK
    Sarepta Ready To Move Higher
    November 19, 2012 | about: SRPT
    By:EfsInvestors
    Sarepta has a wonderful drug in its pipeline, which can dominate the market for years. Unlike many other drugs, Eteplirsen has support from the public who want this drug to be in the market. It has shown phenomenal results and may force the FDA to approve the drug without phase III trials. Regardless of early approval, the stock will continue to move up in the short and medium term. However, if the early approval is granted - the stock will move up rapidly. In addition, it is extremely unlikely that the company will face competition any time soon. I remain particularly optimistic and confident that Sarepta will provide massive returns to investors.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
26.22+1.96(+8.08%)May 22 4:00 PMEDT